GL1X · GenesisL1 explorer

MolNFT v1 · #111350 · protein

Crsystal structure HIV-1 protease MDR769 L33F complexed with darunavir

4YOA: “Crsystal structure HIV-1 protease MDR769 L33F complexed with darunavir”. X-ray diffraction, 1 ligand (017), 1 pocket (best druggability 0.47). MolNFT v1 #111350 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4YOA
Type
protein
Length
99 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
UniProt
Q5RTL1
Ligands
017
Pockets
1 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 proteaseprotein997% helix, 46% strandQ5RTL1

Ligands and binding sites

  • 017 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11470.470.7721empty

Compared structures

  • 4YOA · Crsystal structure HIV-1 Protease MDR769 L33F Complexed with darunavir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.